CSIMarket
 


Zimmer Biomet Holdings Inc   (NYSE: ZBH)
Other Ticker:  
 

Zimmer Biomet Holdings Inc 's Working Capital Ratio

ZBH's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth

 


Zimmer Biomet Holdings Inc 's Current Assets grew by 19.67 % in the Q1 2025 sequentially, while Current Liabilities decreased, this led to improvement in Zimmer Biomet Holdings Inc 's Working Capital Ratio to 2.44, above Zimmer Biomet Holdings Inc average Working Capital Ratio.

Within Medical Equipment & Supplies industry 83 other companies have achieved higher Working Capital Ratio than Zimmer Biomet Holdings Inc in first quarter 2025. While Working Capital Ratio total ranking in the first quarter 2025 has deteriorated compared to the prior quarter from 711 to 1333.

Explain Working Capital Ratio
How much Current Assetss ZBH´s has?
What are ZBH´s Current Liabilities?


ZBH Working Capital Ratio (Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
Y / Y Current Liabilities Change -17.95 % -14.23 % 72.4 % 61.54 % 19.74 %
Y / Y Current Assets Change 20.7 % 1.35 % 11.25 % 5.73 % 4.98 %
Working Capital Ratio MRQ 2.44 1.91 1.36 1.29 1.66
ZBH's Total Ranking # 1333 # 711 # 484 # 2777 # 2188
Seq. Current Liabilities Change -6.37 % -31.37 % -1.03 % 29.01 % -2.11 %
Seq. Current Assets Change 19.67 % -3.96 % 4.84 % 0.17 % 0.48 %



Working Capital Ratio first quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 487
Overall Market # 1333


Working Capital Ratio Statistics
High Average Low
4.07 2.04 1.17
(Dec 31 2013)   (Sep 30 2019)




Financial Statements
Zimmer Biomet Holdings Inc 's Current Liabilities $ 2,295 Millions Visit ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Current Assets $ 5,590 Millions Visit ZBH's Balance sheet
Source of ZBH's Sales Visit ZBH's Sales by Geography


Cumulative Zimmer Biomet Holdings Inc 's Working Capital Ratio

ZBH's Working Capital Ratio for the trailling 12 Months

ZBH Working Capital Ratio

(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 19.74 % 30.84 % 42.61 % 22.89 % 5.35 %
Y / Y Current Assets TTM Growth 9.8 % 5.77 % 6.51 % 2.76 % 0.92 %
Working Capital Ratio TTM 1.66 1.51 1.46 1.61 1.81
Total Ranking TTM # 3395 # 2223 # 3599 # 3581 # 3453
Seq. Current Liabilities TTM Growth -4.04 % -3.17 % 13.23 % 13.8 % 4.85 %
Seq. Current Assets TTM Growth 5.1 % 0.33 % 2.7 % 1.4 % 1.23 %


On the trailing twelve months basis ZBH Current Assets grew by 20.7 % in Q1 2025 year on year, while Current Liabilities decreased to $2,295 millions, this led to increase in in Zimmer Biomet Holdings Inc 's Working Capital Ratio to 1.66, Working Capital Ratio remained below ZBH average.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 194 other companies have achieved higher Working Capital Ratio than Zimmer Biomet Holdings Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 2223 to 3395.

Explain Working Capital Ratio
How much Current Assetss ZBH´s has?
What are ZBH´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 195
Healthcare Sector # 893
Within the Market # 3395


trailing twelve months Working Capital Ratio Statistics
High Average Low
2.2 1.74 1.36
(Mar 31 2021)   (Mar 31 2020)




Companies with similar Working Capital Ratio in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry Working Capital RatioMar 31 2025 MRQ Current AssetsMar 31 2025 MRQ Current Liabilities
Neuropace Inc   6.63 $ 97.478  Millions$ 14.707  Millions
Glaukos Corp  6.49 $ 444.544  Millions$ 68.529  Millions
Penumbra Inc  6.30 $ 999.709  Millions$ 158.630  Millions
Orthopediatrics Corp  6.19 $ 232.059  Millions$ 37.505  Millions
Hyperfine Inc   6.07 $ 48.403  Millions$ 7.979  Millions
Vicarious Surgical Inc  6.02 $ 39.652  Millions$ 6.592  Millions
Anika Therapeutics Inc   5.73 $ 102.509  Millions$ 17.901  Millions
Autonomix Medical Inc   5.63 $ 9.609  Millions$ 1.707  Millions
Artivion Inc   5.53 $ 287.297  Millions$ 51.940  Millions
Tenon Medical Inc  5.46 $ 11.990  Millions$ 2.195  Millions
Heartbeam Inc   5.46 $ 8.608  Millions$ 1.578  Millions
Apyx Medical Corp  5.45 $ 51.851  Millions$ 9.510  Millions
Electromed Inc   5.19 $ 44.195  Millions$ 8.511  Millions
Surmodics Inc   5.14 $ 71.747  Millions$ 13.950  Millions
Merit Medical Systems Inc  5.12 $ 958.635  Millions$ 187.388  Millions
Intuitive Surgical Inc   4.98 $ 7,657.800  Millions$ 1,538.100  Millions
Pulmonx Corporation  4.97 $ 123.939  Millions$ 24.945  Millions
Endra Life Sciences Inc   4.96 $ 2.180  Millions$ 0.440  Millions
Tactile Systems Technology Inc   4.95 $ 160.122  Millions$ 32.365  Millions
Glucotrack Inc   4.85 $ 9.455  Millions$ 1.950  Millions
Staar Surgical Co  4.78 $ 326.498  Millions$ 68.356  Millions
Axogen inc   4.73 $ 93.070  Millions$ 19.658  Millions
Biolife Solutions Inc   4.73 $ 131.129  Millions$ 27.723  Millions
Zynex inc   4.72 $ 56.414  Millions$ 11.945  Millions
Mimedx Group Inc   4.70 $ 200.112  Millions$ 42.619  Millions
Nexalin Technology Inc   4.56 $ 2.621  Millions$ 0.575  Millions
Treace Medical Concepts Inc   4.50 $ 149.437  Millions$ 33.180  Millions
Insulet Corporation  4.47 $ 2,328.400  Millions$ 520.400  Millions
Edwards Lifesciences Corporation  4.45 $ 6,212.700  Millions$ 1,394.800  Millions
Globus Medical Inc   4.45 $ 1,710.114  Millions$ 384.701  Millions

Date modified: 2025-05-06T07:42:26+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com